Multiple myeloma patients N = 239 | |
---|---|
Age (year) | |
Median (range) | 66 (36-89) |
Sex, no. (%) | |
Male | 128 (54) |
Female | 111 (46) |
Phase of disease, no. (%) | |
Newly diagnosed | 87 (36) |
Stable disease | 80 (34) |
Relapse/progression | 69 (29) |
Multiple myeloma treatment during the study, no (%) | |
No treatment | 86 (36) |
MP +/- Thalidomide | 55 (23) |
ASCT, newly diagnosed | 33 (14) |
ASCT, relapse | 8 (3) |
Velcade | 7 (3) |
Thalidomide | 32 (13) |
Other | 15 (6) |
Unknown | 3 (1) |